A detailed history of Charles Schwab Investment Management Inc transactions in Enzo Biochem Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,471 shares of ENZ stock, worth $14,683. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,471
Previous 13,471 -0.0%
Holding current value
$14,683
Previous $18,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.86 - $3.61 $264,658 - $334,062
-92,538 Reduced 87.29%
13,471 $43,000
Q3 2020

Nov 13, 2020

SELL
$2.02 - $3.02 $318,782 - $476,595
-157,813 Reduced 59.82%
106,009 $224,000
Q2 2020

Aug 14, 2020

BUY
$2.12 - $3.22 $33,402 - $50,734
15,756 Added 6.35%
263,822 $591,000
Q1 2020

May 15, 2020

BUY
$1.82 - $3.87 $6,302 - $13,401
3,463 Added 1.42%
248,066 $628,000
Q4 2019

Feb 07, 2020

BUY
$2.57 - $3.68 $6,885 - $9,858
2,679 Added 1.11%
244,603 $644,000
Q3 2019

Nov 08, 2019

SELL
$3.01 - $4.0 $37,345 - $49,628
-12,407 Reduced 4.88%
241,924 $871,000
Q2 2019

Aug 09, 2019

BUY
$2.79 - $4.31 $61,815 - $95,492
22,156 Added 9.54%
254,331 $858,000
Q1 2019

May 14, 2019

SELL
$2.54 - $4.02 $2,534 - $4,011
-998 Reduced 0.43%
232,175 $634,000
Q4 2018

Feb 14, 2019

SELL
$2.46 - $4.2 $7,842 - $13,389
-3,188 Reduced 1.35%
233,173 $649,000
Q3 2018

Nov 13, 2018

BUY
$3.81 - $5.53 $55,134 - $80,024
14,471 Added 6.52%
236,361 $974,000
Q2 2018

Aug 08, 2018

BUY
$5.06 - $6.78 $35,536 - $47,615
7,023 Added 3.27%
221,890 $1.15 Million
Q1 2018

May 07, 2018

BUY
$5.43 - $8.36 $200,752 - $309,077
36,971 Added 20.78%
214,867 $1.18 Million
Q4 2017

Jan 17, 2018

SELL
$8.15 - $10.55 $183,815 - $237,944
-22,554 Reduced 11.25%
177,896 $1.45 Million
Q3 2017

Nov 13, 2017

BUY
$10.45 - $11.44 $2.09 Million - $2.29 Million
200,450
200,450 $2.1 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $53.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.